Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimens
- 31 October 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (11), 1645-1648
- https://doi.org/10.1016/0277-5379(87)90443-3
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Cisplatin.An active drug in the treatment of disseminated gastric cancerCancer, 1984
- Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancerCancer, 1983
- Adenocarcinoma of Unknown Primary OriginSouthern Medical Journal, 1981
- Reporting results of cancer treatmentCancer, 1981
- Unknown primary adenocarcinoma: incidence of overinvestigation and natural history.BMJ, 1979
- UNDIFFERENTIATED CARCINOMA IN YOUNG MEN: THE ATYPICAL TERATOMA SYNDROMEThe Lancet, 1979
- Identifying the Primary Site in Metastatic Cancer of Unknown OriginPublished by American Medical Association (AMA) ,1979
- Germ cell tumors (II). VAB II in metastatic testicular cancerCancer, 1978
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Treatment of the patient with adenocarcinoma of unknown originCancer, 1972